Fig. 1From: Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analysesRelapse-free survival probability according to the American Joint Committee on Cancer (AJCC) response, complete response, partial response, and no-response groupsBack to article page